NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/07/2025
Voltar para busca
Dado oficial do USPTO
AFFIDX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AFFIDX
ST13
US500000079304130Classe
5, 9, 10, 44
Pedido
79304130
Registro
6829613
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
19/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 44
Data de depósito
22/09/2020
Data de registro
30/08/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/08/2022
Última transação
19/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
OAKES, JEFFREY
Unidade examinadora
O10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Avacta Limited
Representantes
Christina M. Licursi Wolf Greenfield & Sacks, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic testing materialsnamely diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testingmedical diagnostic reagents and assays for testing of body fluidsdiagnostic agentspreparations and substances for medical purposes; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testingmedical diagnostic reagents and assays for testing of body fluidsdiagnostic agentspreparations and substances for medical purposespreparations for medical testing purposes and test strips for medical testing purposes namely for testing for the detection and diagnosis of covid-19 and influenza; diagnostic materials being diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testingmedical diagnostic reagents and assays for testing of body fluidsdiagnostic agentspreparations and substances for medical purposespreparations for medical testing purposes and test strips for lateral flow medical testing purposes namely for the detection and diagnosis of covid-19 and influenza; diagnostic reagents for medical purposes; diagnostic testing materials being diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testingmedical diagnostic reagents and assays for testing of body fluidsdiagnostic agentspreparations and substances for medical purposes for the detection and diagnosis of covid-19 and influenza; diagnostic preparations for medical testing purposes; materials namely diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testingmedical diagnostic reagents and assays for testing of body fluidsdiagnostic agentspreparations and substances for medical purposesmedical diagnostic strips for lateral flow medical testing purposes namely for the detection and diagnosis of covid-19 and influenzadiagnostic reagents for medical testing purposesall for the detection and diagnosis of covid-19 and influenza
Classe 9
Downloadable software in the nature of mobile application software for medical diagnostics; Downloadable software in the nature of mobile application software for the collectionanalysis and reporting of diagnostic tests; downloadable mobile application software for the collectionanalysis and reporting of diagnostic tests for Covid-19 and influenza
Classe 10
Medical testing apparatusinstruments and equipment for diagnostic use namely apparatus for medical diagnostic testing for the detection and diagnosis of covid-19 and influenza; medical testing apparatusinstruments and equipment for the detection and diagnosis of Covid-19 and influenzanamely medical diagnostic apparatus for testing for virusesmedical diagnostic instruments for the analysis of body fluidsapparatus for virus testing purposes
Classe 44
Medical diagnostic testing being medical testing for diagnostic or treatment purposesanalysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing being medical testing for diagnostic or treatment purposesanalysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing being medical testing for diagnostic or treatment purposesanalysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; medical testing being medical testing for diagnostic or treatment purposes and analysis services namely medical analysis services for diagnostic and treatment purposes provided by medical laboratories for covid-19 and influenza; advisory and information services relating to all the aforesaid
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/07/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/07/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/07/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/07/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/12/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/12/2022
FIMP
FINAL DISPOSITION PROCESSED
07/12/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/11/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
30/08/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/08/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/07/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
13/07/2022
GPNX
NOTIFICATION PROCESSED BY IB
05/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/06/2022
PUBO
PUBLISHED FOR OPPOSITION
14/06/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/06/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/05/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/05/2022
GNRT
NON-FINAL ACTION E-MAILED
09/05/2022
CNRT
NON-FINAL ACTION WRITTEN
09/05/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/04/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
18/04/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
31/08/2021
GNSL
LETTER OF SUSPENSION E-MAILED
31/08/2021
CNSL
SUSPENSION LETTER WRITTEN
31/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/08/2021
RFNT
REFUSAL PROCESSED BY IB
15/03/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/02/2021
RFRR
REFUSAL PROCESSED BY MPU
22/02/2021
MAFR
APPLICATION FILING RECEIPT MAILED
16/02/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/02/2021
CNRT
NON-FINAL ACTION WRITTEN
12/02/2021
DOCK
ASSIGNED TO EXAMINER
12/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/02/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AFFIDX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.